Doceree appoints Anil Dobhal as global chief technology officer
Doceree, a global platform building solutions for healthcare professionals (HCP) programmatic marketing with proprietary data tools, has announced the appointment of Anil Dobhal as global chief technology officer.
Dobhal brings with him more than over 24 years of rich technical experience in building strong bid landscapes and data security infrastructures in the consumer marketing domain. He will lead Doceree’s global technology and product teams spanning the US, Europe and those in the emerging markets.
“I am excited to join Doceree at this critical juncture when it is building a sustainable and scalable global programmatic ecosystem for the pharma and life sciences industry. My key focus will be on automating the programmatic ecosystem with AI, ML and data science algorithms that optimise marketing initiatives of pharma and life sciences companies and ensure better RPMs (ad revenue per thousand impressions) for publishers,” said Dobhal.
A start-up and ad-tech enthusiast, Dobhal has extensive knowledge of fraud systems. In his past roles, he built scalable data security systems that dealt with huge volume. “I intend to replicate those vast learnings from consumer space to build extensive designs and structures that will enrich our programmatic offerings to serve the varied market needs,” said Dobhal.
Prior to joining Doceree, he successfully defined, implemented, and commercialised solutions across different industries, including at Times Internet Limited, Expedia, One97 Communications and GlobalLogic, evolving solutions around large scale databases, BI Stacks, and big data platforms, among others.
“Pharma marketing is going through transformational times with hybrid approaches taking centerstage for most businesses. We are excited about Anil being a part of our next crucial journey of growth and expansion,” said Harshit Jain MD, founder and global CEO, Doceree.
“We are focused on empowering our clients and partners with high-end technology solutions led by artificial intelligence (AI) and machine learning (ML). Anil’s deep expertise in programmatic design will help us utilize humungous data to churn valuable insights for our partners world over, enabling them to make key business decisions and optimize business outcomes in a very secure and transparent manner.”
Doceree’s breakthrough proprietary identity-resolution technology ESPYIANTM identifies and precision targets healthcare professionals using AI, data integration, and data analytics. The company, which raised Series A funding of $11 million from reputed global investors, including Eight Roads Ventures, plans to create world-leading programmatic solutions in the space of pharma marketing.